<img alt="" src="https://secure.perk0mean.com/184504.png" style="display:none;">

4G Clinical

Blog

The Site Perspective: COVID-19 and the movement towards Direct-to-Patient trials

4G Clinical

 

Q&A with a clinical research site discussing COVID-19 and the movement towards Direct-to-Patient trials.

Is Now The Right Time To Switch To Direct-to-Patient (DtP) Trials?

4G Clinical

 

Direct-to-Patient (DtP) trials are more prevalent than ever before. Here are 5 questions to ask yourself when planning a DtP trial.

Industry Calls for Improved Clinical Supply Forecasting Solution

4G Clinical

 

In this interview, two senior industry clinical trial supply professionals discuss experiences with manual tools and existing commercial solutions, as well as the need for an improved clinical supply forecasting solution.

Integrations Made Simple – An Intelligent Conversation Between Systems

4G Clinical

 

Integrations don't need to involve complicated coding to develop. Modern tech can simplify implementation and enable a conversation between systems.

Power of Excel & The Case for Moving Beyond the Beloved Tool for Clinical Trial Forecasting

4G Clinical

 

Excel is a great tool for planning. It's easy to use and for experienced users provides insight into data. But is it the best choice for your trial?

Should Clinical Supply Planners be Statistical Experts?

4G Clinical

 

CSPs should be empowered with a good level of understanding what variables or information is critical to model supply planning (feasibility planning to study planning) so they can react and make decisions more effectively.

As Clinical Trials Evolve, Will Your Systems Keep Up?

4G Clinical

 

Over the life of a study, the amount of time and resources spent on changes to a system can significantly impact the study – but do they have to?

Top 5 Questions to Ask When Considering RTSM Systems for Phase 1 Clinical Trials

4G Clinical

 

Did you know that Phase 1 trials can be even more complex than their Phase 2 and 3 counterparts? Don't let scale be the determining factor in choosing to leverage an RTSM. Here are 5 questions to ask when you consider an RTSM for your next Phase 1 study.

Top 6 Benefits of Leveraging an RTSM for Investigator Initiated Trials (IITs)

4G Clinical

 

Having an IRT/RTSM for your IITs will help with supply chain management since IITs traditionally draw from the same pool of drugs as manufacturer-sponsored studies. See how.

A Night Filled with Entrepreneurial Spirit

4G Clinical

 

On Wednesday, June 26th, 4G Clinical co-founders David Kelleher and Ed Tourtellotte were recognized as finalists for EY’s Entrepreneur Of The Year ®2019 Award for the New England region. An impressive group of unstoppable entrepreneurs from 36 companies across many industries celebrated entrepreneurship throughout the evening at the Westin Waterfront hotel in Boston.